[
    [
        {
            "time": "",
            "original_text": "健讯Daily｜华大基因获33亿元国际大单；Moderna首款季节性流感疫苗获突破；万泰生物建5亿份IVD试剂生产基地",
            "features": {
                "keywords": [
                    "华大基因",
                    "33亿元",
                    "国际大单",
                    "Moderna",
                    "季节性流感疫苗",
                    "突破",
                    "万泰生物",
                    "IVD试剂",
                    "生产基地"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "医疗设备"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因获33亿元国际大单",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]